Metabolic Fuel and Clinical Implications for Female Reproduction

Journal of Obstetrics and Gynaecology Canada

Volumn 29, Issue 11, 2007, Pages 887-902

  Mircea, Carmen N ^a   Lujan, Marla E ^a   Pierson, Roger A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Appetite; Metabolic fuel; Nutritional amenorrhea; Obesity; Reproduction

Indexed keywords

ADIPONECTIN; AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; BETA ENDORPHIN; CATECHOLAMINE; CHOLECYSTOKININ; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CORTICOTROPIN; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GONADORELIN; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; KISSPEPTIN; LEPTIN; LUTEINIZING HORMONE; MELANOCORTIN; NEUROPEPTIDE Y; OREXIN; PEPTIDE YY [3-36]; TUMOR NECROSIS FACTOR ALPHA; CORTICOSTEROID;

AMENORRHEA; ARTICLE; COMORBIDITY; ENERGY BALANCE; ENERGY EXPENDITURE; ENVIRONMENTAL FACTOR; FEMALE INFERTILITY; FEMALE REPRODUCTION; FOOD AVAILABILITY; FOOD INTAKE; GONADORELIN RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RELEASE; INSULIN SENSITIVITY; LACTATION; LIFESTYLE; LIPOLYSIS; LUTEINIZING HORMONE RELEASE; METABOLIC REGULATION; NONHUMAN; OBESITY; OVARY CYCLE; PREGNANCY; PREGNANCY OUTCOME; PUBERTY; PUBERTY DISORDERS; REPRODUCTION; SEXUAL BEHAVIOR; SOCIOECONOMICS; STEROIDOGENESIS; ENERGY METABOLISM; FEMALE; HUMAN; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADRENAL CORTEX HORMONES; ENERGY METABOLISM; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFERTILITY, FEMALE; LUTEINIZING HORMONE; OVARY; PREGNANCY; REPRODUCTION;

EID: 38449094109     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32661-5     Document Type: Article

References (219)

1. Bronson F.H. Mammalian reproductive biology 1989, 325. University of Chicago Press, Chicago.
2. Schneider J.E. Energy balance and reproduction. Physiol Behav 2004, 81(2):289-317.
3. Wade G.N., Schneider J.E. Metabolic fuels and reproduction in female mammals. Neurosci Biobehav Rev 1992, 16(2):235-272.
4. Booth P.J. Metabolic influences on hypothalamic-pituitary-ovarian function in the pig. J Reprod Fertil Suppl 1990, 40:89-100.
5. I'Anson H. Nutrition and reproduction. Oxf Rev Reprod Biol 1991, 13:239-311.
6. Warren M.P. Effects of undernutrition on reproductive function in the human. Endocr Rev 1983, 4(4):363-377.
7. Steiner R.A. Nutritional and metabolic factors in the regulation of reproductive hormone secretion in the primate. Proc Nutr Soc 1987, 46(2):159-175.
8. Cameron J.L. Nutritional determinants of puberty. Nutr Rev 1996, 54(2 Pt 2):S17-S22.
9. Otis C.L., Drinkwater B., Johnson M., Loucks A., Wilmore J. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 1997, 29(5):i-ix.
10. Berga S.L. Functional hypothalamic amenorrhea. Current Opinion in Endocrinology, Diabetes and Obesity 2001, 8(6):307-313.
11. Linne Y. Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev 2004, 5(3):137-143.
12. Ramsay J.E., Greer I., Sattar N. ABC of obesity. Obesity and reproduction. BMJ 2006, 333(7579):1159-1162.
13. Wild R.A. Long-term health consequences of PCOS. Hum Reprod Update 2002, 8(3):231-241.
14. Schneider J.G., Tompkins C., Blumenthal R.S., Mora S. The metabolic syndrome in women. Cardiol Rev 2006, 14(6):286-291.
15. Canadian Task Force on Preventive Health Care New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003, 169(3):207-208.
16. Schneider J.E., Wade G.N. Availability of metabolic fuels controls estrous cyclicity of Syrian hamsters. Science 1989, 244(4910):1326-1328.
17. Bucholtz D.C., Vidwans N.M., Herbosa C.G., Schillo K.K., Foster D.L. Metabolic interfaces between growth and reproduction. V. Pulsatile luteinizing hormone secretion is dependent on glucose availability. Endocrinology 1996, 137(2):601-607.
18. Cameron J.L. Regulation of reproductive hormone secretion in primates by short-term changes in nutrition. Rev Reprod 1996, 1(2):117-126.
19. Nagatani S., Bucholtz D.C., Murahashi K., Estacio M.A., Tsukamura H., Foster D.L., et al. Reduction of glucose availability suppresses pulsatile luteinizing hormone release in female and male rats. Endocrinology 1996, 137(4):1166-1170.
20. Ohkura S., Tanaka T., Nagatani S., Bucholtz D.C., Tsukamura H., Maeda K., et al. Central, but not peripheral, glucose-sensing mechanisms mediate glucoprivic suppression of pulsatile luteinizing hormone secretion in the sheep. Endocrinology 2000, 141(12):4472-4480.
21. Cameron J.L., Nosbisch C. Suppression of pulsatile luteinizing hormone and testosterone secretion during short term food restriction in the adult male rhesus monkey (Macaca mulatta). Endocrinology 1991, 128(3):1532-1540.
22. Cameron J.L., Helmreich D.L., Schreihofer D.A. Modulation of reproductive hormone secretion by nutritional intake: stress signals versus metabolic signals. Hum Reprod 1993, 8(Suppl 2):162-167.
23. Loucks A.B. Energy availability, not body fatness, regulates reproductive function in women. Exerc Sport Sci Rev 2003, 31(3):144-148.
24. Loucks A.B., Thuma J.R. Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab 2003, 88(1):297-311.
25. Williams N.I., Caston-Balderrama A.L., Helmreich D.L., Parfitt D.B., Nosbisch C., Cameron J.L. Longitudinal changes in reproductive hormones and menstrual cyclicity in cynomolgus monkeys during strenuous exercise training: abrupt transition to exercise-induced amenorrhea. Endocrinology 2001, 142(6):2381-2389.
26. Lujan M.E., Krzemien A.A., Reid R.L., Van Vugt D.A. Developing a model of nutritional amenorrhea in rhesus monkeys. Endocrinology 2006, 147(1):483-492.
27. Frisch R.E., Revelle R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science 1970, 169(943):397-399.
28. Frisch R.E. Body fat, menarche, fitness and fertility. Hum Reprod 1987, 2(6):521-533.
29. Frisch R.E. The right weight: body fat, menarche and ovulation. Baillieres Clin Obstet Gynaecol 1990, 4(3):419-439.
30. Warren M.P. The effects of exercise on pubertal progression and reproductive function in girls. J Clin Endocrinol Metab 1980, 51(5):1150-1157.
31. Abraham S.F., Beumont P.J., Fraser I.S., Llewellyn-Jones D. Body weight, exercise and menstrual status among ballet dancers in training. Br J Obstet Gynaecol 1982, 89(7):507-510.
32. Wade G.N., Schneider J.E., Li H.Y. Control of fertility by metabolic cues. Am J Physiol 1996, 270(1 Pt 1):E1-E19.
33. Glick Z., Yamini S., Lupien J., Sod-Moriah U. Estrous cycle irregularities in overfed rats. Physiol Behav 1990, 47(2):307-310.
34. Clark A.M., Ledger W., Galletly C., Tomlinson L., Blaney F., Wang X., et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995, 10(10):2705-2712.
35. Mitchell M., Armstrong D.T., Robker R.L., Norman R.J. Adipokines: implications for female fertility and obesity. Reproduction 2005, 130(5):583-597.
36. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372(6505):425-432.
37. Budak E., Fernandez Sánchez M., Bellver J., Cerveró A., Simón C., Pellicer A. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril 2006, 85(6):1563-1581.
38. Oral E.A., Ruiz E., Andewelt A., Sebring N., Wagner A.J., Depaoli A.M. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J Clin Endocrinol Metab 2002, 87(7):3110-3117.
39. Cunningham M.J., Clifton D.K., Steiner R.A. Leptin's actions on the reproductive axis: perspectives and mechanisms. Biol Reprod 1999, 60(2):216-222.
40. Jin L., Burguera B.G., Couce M.E., Scheithauer B.W., Lamsan J., Eberhardt N.L., et al. Leptin and leptin receptor expression in normal and neoplastic human pituitary: evidence of a regulatory role for leptin on pituitary cell proliferation. J Clin Endocrinol Metab 1999, 84(8):2903-2911.
41. Karlsson C., Lindell K., Svensson E., Bergh C., Lind P., Billig H., et al. Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab 1997, 82(12):4144-4148.
42. Chehab F.F., Lim M.E., Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996, 12(3):318-320.
43. Yu W.H., Kimura M., Walczewska A., Karanth S., McCann S.M. Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci USA 1997, 94(3):1023-1028.
44. Magni P., Motta M., Martini L. Leptin: a possible link between food intake, energy expenditure, and reproductive function. Regul Pept 2000, 92(1-3):51-56.
45. Judd S.J. Disturbance of the reproductive axis induced by negative energy balance. Reprod Fertil Dev 1998, 10(1):65-72.
46. Miller K.K., Parulekar M.S., Schoenfeld E., Anderson E., Hubbard J., Khbanski A., et al. Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. J Clin Endocrinol Metab 1998, 83(7):2309-2312.
47. Laughlin G.A., Yen S.S. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab 1997, 82(1):318-321.
48. Moschos S., Chan J.L., Mantzoros C.S. Leptin and reproduction: a review. Fertil Steril 2002, 77(3):433-44.
49. Welt C.K., Chan J.L., Bullen J., Murphy R., Smith P., DePaoli A.M., et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004, 351(10):987-997.
50. Lujan M.E., Krzemien A.A., Reid R.L., Van Vugt D.A. Effect of leptin administration on ovulation in food-restricted rhesus monkeys. Neuroendocrinology 2006, 84(2):103-114.
51. Ganong W.F. Review of medical physiology 2005, The McGraw-Hill Companies, New York. 22nd ed.
52. Spanswick D., Smith M.A., Mirshamsi S., Routh V.H., Ashford M.L. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 2000, 3(8):757-758.
53. Pocai A., Lam T.K., Gutierrez-Juarez R., Obici S., Schwartz G.J., Bryan J., et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005, 434(7036):1026-1031.
54. Patel K., Coffler M.S., Dahan M.H., Yoo R.Y., Lawson M.A., Malcom P.J., et al. Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion. J Clin Endocrinol Metab 2003, 88(11):5456-5461.
55. Brüning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289(5487):2122-2125.
56. Laughlin G.A., Dominguez C.E., Yen S.S. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1998, 83(1):25-32.
57. Moran L., Norman R.J. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004, 18(5):719-736.
58. Oral E.A. Lipoatrophic diabetes and other related syndromes. Rev Endocr Metab Disord 2003, 4(1):61-77.
59. Musso C., Cochran E., Javor E., Young J., Depaoli A.M., Gorden P. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients. Metabolism 2005, 54(2):255-263.
60. Dunaif A. Insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2006, 86(Suppl 1):S13-S14.
61. Kasper D.L. Harrison's Principles of internal medicine 2005, The McGraw-Hill Companies, New York. 16th ed.
62. Chrousos G.P., Torpy D.J., Gold P.W. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998, 129(3):229-240.
63. Saketos M., Sharma N., Santoro N.F. Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biol Reprod 1993, 49(6):1270-1276.
64. Dubey A.K., Plant T.M. A suppression of gonadotropin secretion by cortisol in castrated male rhesus monkeys (Macaca mulatta) mediated by the interruption of hypothalamic gonadotropin-releasing hormone release. Biol Reprod 1985, 33(2):423-431.
65. Boccuzzi G., Angeli A., Bisbocci D., Fonzo D., Giadano G.P., Ceresa F. Effect of synthetic luteinizing hormone releasing hormone (LH-RH) on the release of gonadotropins in Cushing's disease. J Clin Endocrinol Metab 1975, 40(5):892-895.
66. Kaye W.H., Berrettini W.H., Gwirtsman H.E., Gold P.W., George D.T., Jimerson D.C., et al. Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa. Psychopharmacol Bull 1989, 25(3):433-438.
67. Blum R.M., Schneider J.E. Fasting-induced anestrus is associated with low, while insulin-induced anestrus is associated with high plasma leptin concentrations 2000, Society for Neurosciences Annual Meeting, New Orleans, Louisiana, November.
68. Blum R.M., Schneider J.E. Food-deprivation induced anestrus does not require adrenal secretion in Syrian hamsters 2003, Society for Behavioral Neuroendocrinology, Cincinnati, Ohio.
69. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402(6762):656-660.
70. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 2001, 409(6817):194-198.
71. Furuta M., Funabashi T., Kimura F. Suppressive action of orexin A on pulsatile luteinizing hormone secretion is potentiated by a low dose of estrogen in ovariectomized rats. Neuroendocrinology 2002, 75(3):151-157.
72. Melis M.R., Mascia M.S., Succu S., Torsello A., Muller E.E., Deghenghi R., et al. Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection. Neurosci Lett 2002, 329(3):339-343.
73. Henry B.A. Links between the appetite regulating systems and the neuroendocrine hypothalamus: lessons from the sheep. J Neuroendocrinol 2003, 15(7):697-709.
74. Zigman J.M., Elmquist J.K. Minireview: from anorexia to obesity-the yin and yang of body weight control. Endocrinology 2003, 144(9):3749-3756.
75. Inui A., Asakawa A., Bowers C.Y., Mantovani G., Laviano A., Meguid M.M., et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 2004, 18(3):439-456.
76. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407(6806):908-913.
77. Wren A.M., Small C.J., Fribbens C.V., Neary N.M., Ward H.L., Seal L.J., et al. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 2002, 76(5):316-324.
78. Faulconbridge L.F., Cummings D.E., Kaplan J.M., Grill H.J. Hyperphagic effects of brainstem ghrelin administration. Diabetes 2003, 52(9):2260-2265.
79. Fernandez-Fernandez R., Tena-Sempere M., Navarro V.M., Barreiro M.L., Castellano J.M., Aguilar E., et al. Effects of Ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: in vivo and in vitro studies. Neuroendocrinology 2006, 82(5-6):245-255.
80. Fernandez-Fernandez R., Navarro V.M., Barreiro M.L., Vigo E.M., Tovar S., Sirotkin A.V., et al. Effects of chronic hyperghrelinemia on puberty onset and pregnancy outcome in the rat. Endocrinology 2005, 146(7):3018-3025.
81. De Souza M.J., Leidy H.J., O'Donnell E., Lasley B., Williams N.I. Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004, 89(7):3536-3542.
82. Misra M., Miller K.K., Kuo K., Griffin K., Stewart V., Hunter E., et al. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 2005, 289(2):E347-E356.
83. Garcia J.M., Garcia-Touza M., Hijazi R.A., Taffet G., Epner D., Mann D., et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 2005, 90(5):2920-2926.
84. Schneider L.F., Warren M.P. Functional hypothalamic amenorrhea is associated with elevated ghrelin and disordered eating. Fertil Steril 2006, 86(6):1744-1749.
85. Vulliémoz N.R., Xiao E., Xia-Zhang L., Germond M., Rivier J., Ferin M. Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab 2004, 89(11):5718-5723.
86. Van Vugt D.A., Lujan M.E., Froats M., Krzemien A., Couceyro P.R., Reid R.L. Effect of fasting on cocaine-amphetamine-regulated transcript, neuropeptide Y, and leptin receptor expression in the non-human primate hypothalamus. Neuroendocrinology 2006, 84(2):83-93.
87. Grove K.L., Chen P., Koegler F.H., Schiffmaker A., Susan Smith M., Cameron J.L. Fasting activates neuropeptide Y neurons in the arcuate nucleus and the paraventricular nucleus in the rhesus macaque. Brain Res Mol Brain Res 2003, 113(1-2):133-138.
88. Schwartz M.W., Baskin D.G., Bukowski T.R., Kuijper J.L., Foster D., Lasser G., et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996, 45(4):531-535.
89. Mercer J.G., Hoggard N., Williams L.M., Lawrence C.B., Hannah L.T., Morgan P.J., et al. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996, 8(10):733-735.
90. Kaynard A.H., Pau K.Y., Hess D.L., Spies H.G. Third-ventricular infusion of neuropeptide Y suppresses luteinizing hormone secretion in ovariectomized rhesus macaques. Endocrinology 1990, 127(5):2437-2444.
91. Kalra S.P., Horvath T., Naftolin F., Xu B., Pu S., Kalra P.S. The interactive language of the hypothalamus for the gonadotropin releasing hormone (GNRH) system. J Neuroendocrinol 1997, 9(8):569-576.
92. Terasawa E. Steroid modulation of pulsatile LHRH release in the rhesus monkey. Horm Behav 1994, 28(4):406-416.
93. Pau K.Y., Berria M., Hess D.L., Spies H.G. Hypothalamic site-dependent effects of neuropeptide Y on gonadotropin-releasing hormone secretion in rhesus macaques. J Neuroendocrinol 1995, 7(1):63-67.
94. Plant T.M., Shahab M. Neuroendocrine mechanisms that delay and initiate puberty in higher primates. Physiol Behav 2002, 77(4-5):717-722.
95. Shahab M., Balasubramaniam A., Sahu A., Plant T.M. Central nervous system receptors involved in mediating the inhibitory action of neuropeptide Y on luteinizing hormone secretion in the male rhesus monkey (Macaca mulatta). J Neuroendocrinol 2003, 15(10):965-970.
96. Kaye W.H. Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res 1996, 62(1):65-74.
97. Oewiecimska J., Ziora K., Geisler G., Broll-Waeka K. Prospective evaluation of leptin and neuropeptide Y (NPY) serum levels in girls with anorexia nervosa. Neuro Endocrinol Lett 2005, 26(4):301-304.
98. B3ogowska A., Krzyzanowska-Swiniarska B., Zielihska D., Rzepka-Gorska I. Body composition and concentrations of leptin, neuropeptide Y, beta-endorphin, growth hormone, insulin-like growth factor-I and insulin at menarche in girls with constitutional delay of puberty. Gynecol Endocrinol 2006, 22(5):274-278.
99. 3onowski A. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Gynecol Endocrinol 1999, 13(5):344-351.
100. Schioth H.B., Watanobe H. Melanocortins and reproduction. Brain Res Brain Res Rev 2002, 38(3):340-350.
101. Kask A., Schioth H.B., Harro J., Wikberg J.E., Ràgo L. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists. Can J Physiol Pharmacol 2000, 78(2):143-149.
102. Marsh D.J., Miura G.I., Yagaloff K.A., Schwartz M.W., Barsh G.S., Palmiter R.D. Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues. Brain Res 1999, 848(1-2):66-77.
103. Kask A., Ràgo L., Wikberg J.E., Schioth H.B. Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur J Pharmacol 1998, 360(1):15-19.
104. Stanley S.A., Davies S., Small C.J., Gardiner J.V., Ghatei M.A., Smith D.M., et al. gamma-MSH increases intracellular cAMP accumulation and GnRH release in vitro and LH release in vivo. FEBS Lett 2003, 543(1-3):66-70.
105. Farooqi I.S. Leptin and the onset of puberty: insights from rodent and human genetics. Semin Reprod Med 2002, 20(2):139-144.
106. Douglass J., Daoud S. Characterization of the human cDNA and genomic DNA encoding CART: a cocaine- and amphetamine-regulated transcript. Gene 1996, 169(2):241-245.
107. Elias C.F., Lee C.E., Kelly J.F., Ahima R.S., Kuhar M., Saper C.B., et al. Characterization of CART neurons in the rat and human hypothalamus. J Comp Neurol 2001, 432(1):1-19.
108. Dall Vechia S., Lambert P.D., Couceyro P.C., Kuhar M.J., Smith Y. CART peptide immunoreactivity in the hypothalamus and pituitary in monkeys: analysis of ultrastructural features and synaptic connections in the paraventricular nucleus. J Comp Neurol 2000, 416(3):291-308.
109. Wierup N., Richards W.G., Bannon A.W., Kuhar M.J., Ahrén B., Sundler F. CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul Pept 2005, 129(1-3):203-211.
110. Parent A.S., Lebrethon M.C., Gérard A., Vandersmissen E., Bourguignon J.P. Leptin effects on pulsatile gonadotropin releasing hormone secretion from the adult rat hypothalamus and interaction with cocaine and amphetamine regulated transcript peptide and neuropeptide Y. Regul Pept 2000, 92(1-3):17-24.
111. Baranowska B., Wolinska-Witort E., Chmielowska M., Martynska L., Baranowska-Bik A. Direct effects of cocaine-amphetamine-regulated transcript (CART) on pituitary hormone release in pituitary cell culture. Neuro Endocrinol Lett 2003, 24(3-4):224-226.
112. Kuriyama G., Takekoshi S., Tojo K., Nakai Y., Kuhar M.J., Osamura R.Y. Cocaine- and amphetamine-regulated transcript peptide in the rat anterior pituitary gland is localized in gonadotrophs and suppresses prolactin secretion. Endocrinology 2004, 145(5):2542-2550.
113. Kobayashi Y., Jimenez-Krassel F., Li Q., Yao J., Huang R., Ireland J.J., et al. Evidence that cocaine- and amphetamine-regulated transcript is a novel intraovarian regulator of follicular atresia. Endocrinology 2004, 145(11):5373-5383.
114. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92(4):573-585.
115. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92(5):1. page following 696.
116. Diano S., Horvath B., Urbanski H.F., Sotonyi P., Horvath T.L. Fasting activates the nonhuman primate hypocretin (orexin) system and its postsynaptic targets. Endocrinology 2003, 144(9):3774-3778.
117. Ramsey J.J., Kemnitz J.W., Newton W., Hagopian K., Patterson T.A., Swick A.G. Food intake in rhesus monkeys following central administration of orexins. Regul Pept 2005, 124(1-3):209-214.
118. Martynska L., Wolinska-Witort E., Chmielowska M., Bik W., Baranowska B. The physiological role of orexins. Neuro Endocrinol Lett 2005, 26(4):289-292.
119. Horvath T.L., Diano S., van den Pol A.N. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 1999, 19(3):1072-1087.
120. Campbell H.J. The effect of steroid hormones on self-stimulation, central and peripheral. Steroidologia 1970, 1(1):8-24.
121. Sasson R., Dearth R.K., White R.S., Chappell P.E., Mellon P.L. Orexin A Induces GnRH Gene Expression and Secretion from GT1-7 Hypothalamic GnRH Neurons. Neuroendocrinology 2006, 84(6):353-363.
122. Russell S.H., Small C.J., Kennedy A.R., Stanley S.A., Seth A., Murphy K.G., Taheri S., et al. Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology 2001, 142(12):5294-5302.
123. Jain M.R., Horvath T.L., Kalra P.S., Kalra S.P. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats. Regul Pept 2000, 87(1-3):19-24.
124. Blanco M., Gallego R., García-Caballero T., Diéguez C., Beiras A. Cellular localization of orexins in human anterior pituitary. Histochem Cell Biol 2003, 120(4):259-264.
125. Estour B., Pugeat M., Lang F., Lejeune H., Broutin F., Pellet J., et al. Rapid escape of cortisol from suppression in response to i.v. dexamethasone in anorexia nervosa. Clin Endocrinol (Oxf) 1990, 33(1):45-52.
126. Porkka-Heiskanen T., Kalinchuk A., Alanko L., Huhtaniemi I., Stenberg D. Orexin A and B levels in the hypothalamus of female rats: the effects of the estrous cycle and age. Eur J Endocrinol 2004, 150(5):737-742.
127. Silveyra P., Catalano P.N., Lux-Lantos V., Libertun C. Impact of the proestrous milieu on the expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis. Actions of cetrorelix and nembutal. AmJ Physiol Endocrinol Metab 2007 Mar, 292(3):E820-E828. Epub 2006 Nov 22.
128. Kok S.W., Roelfsema F., Overeem S., Lammers G.J., Frolich M., Meinders A.E., et al. Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab 2004, 287(4):E630-E636.
129. Ohtani H., Mouri T., Sasaki A., Sasano N. Immunoelectron microscopic study of corticotropin-releasing factor in the human hypothalamus and pituitary gland. Neuroendocrinology 1987, 45(2):104-108.
130. Williams C.L., Nishihara M., Thalabard J.C., Grosser P.M., Hotchkiss J., Knobil E. Corticotropin-releasing factor and gonadotropin-releasing hormone pulse generator activity in the rhesus monkey. Electrophysiological studies. Neuroendocrinology 1990, 52(2):133-137.
131. Gambacciani M., Yen S.S., Rasmussen D.D. GnRH release from the mediobasal hypothalamus: in vitro inhibition by corticotropin-releasing factor. Neuroendocrinology 1986, 43(4):533-536.
132. De Souza E.B., Perrin M.H., Insel T.R., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. Science 1984, 224(4656):1449-1451.
133. Gindoff P.R., Ferin M. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate. Endocrinology 1987, 121(3):837-842.
134. Barbarino A., De Marinis L., Tofani A., Della Casa S., D'Amico C., Mancini A., et al. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade. J Clin Endocrinol Metab 1989, 68(3):523-528.
135. Kaye W.H., Gwirtsman H.E., George D.T., Ebert M.H., Jimerson D.C., Tomai T.P., et al. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocrinol Metab 1987, 64(2):203-208.
136. Casanueva F.F., Borras C.G., Burguera B., Muruais C., Fernández M., Devesa J. Steroids and neuroendocrine function in anorexia nervosa. J Steroid Biochem 1987, 27(1-3):635-640.
137. Samuels M.H., Sanborn C.F., Hofeldt F., Robbins R. The role of endogenous opiates in athletic amenorrhea. Fertil Steril 1991, 55(3):507-512.
138. Schneider J.E., Wade G.N. Decreased availability of metabolic fuels induces anestrus in golden hamsters. Am J Physiol 1990, 258(3 Pt 2):R750-R755.
139. Palmert M.R., Radovick S., Boepple P.A. Leptin levels in children with central precocious puberty. J Clin Endocrinol Metab 1998, 83(7):2260-2265.
140. Blogowska A., Rzepka-Gorska I., Krzyzanowska-Swiniarska B. Is neuropeptide Y responsible for constitutional delay of puberty in girls? A preliminary report. Gynecol Endocrinol 2004, 19(1):22-25.
141. Maffeis C., Franceschi R., Moghetti P., Camilot M., Lauriola S., Tato L. Circulating ghrelin levels in girls with central precocious puberty are reduced during treatment with LHRH analog. Eur J Endocrinol 2007, 156(1):99-103.
142. Gamba M., Pralong F.P., Gamba M., Pralong F.P. Control of GnRH neuronal activity by metabolic factors: the role of leptin and insulin. Mol Cell Endocrinol 2006, 254-255. 133-9.
143. Tomasik P.J., Spodaryk M., Sztefko K. Plasma concentrations of orexins in children. Ann Nutr Metab 2004, 48(4):215-220.
144. Ibanez L., Ong K., Valls C., Marcos M.V., Dunger D.B., de Zegher F. Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 2006, 91(8):2888-2891.
145. Plazzi G., Parmeggiani A., Mignot E., Lin L., Scano M.C., Posar A., et al. Narcolepsy-cataplexy associated with precocious puberty. Neurology 2006, 66(10):1577-1579.
146. Clement K., Clément K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392(6674):398-401.
147. Ozata M., Ozdemir I.C., Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999, 84(10):3686-3695.
148. Farooqi I.S., Jebb S.A., Langmack G., Lawrence E., Cheetham C.H., Prentice A.M., et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N EnglJ Med 1999, 341(12):879-884.
149. Plant T.M., Zorub D.S. A study of the role of the adrenal glands in the initiation of the hiatus in gonadotropin secretion during prepubertal development in the male rhesus monkey (Macaca mulatta). Endocrinology 1984, 114(2):560-565.
150. Cheung C.C., Thornton J.E., Nurani S.D., Clifton D.K., Steiner R.A. A reassessment of leptin's role in triggering the onset of puberty in the rat and mouse. Neuroendocrinology 2001, 74(1):12-21.
151. Reid R.L., Van Vugt D.A. Weight-related changes in reproduction function. Fertil Steril 1987, 48(6):905-913.
152. Warren M.P., Stiehl A.L. Exercise and female adolescents: effects on the reproductive and skeletal systems. J Am Med Womens Assoc 1999, 54(3):115-120. 138.
153. Boyar R.M., Katz J., Finkelstein J.W., Kapen S., Weiner H., Weitzman E.D., et al. Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern. N Engl J Med 1974, 291(17):861-865.
154. De Souza M.J., Metzger D.A. Reproductive dysfunction in amenorrheic athletes and anorexic patients: a review. Med Sci Sports Exerc 1991, 23(9):995-1007.
155. Goodman L.R., Warren M.P. The female athlete and menstrual function. Curr Opin Obstet Gynecol 2005, 17(5):466-470.
156. Warren M.P., Holderness C.C., Lesobre V., Tzen R., Vossoughian F., Brooks-Gunn J. Hypothalamic amenorrhea and hidden nutritional insults. J Soc Gynecol Investig 1994, 1(1):84-88.
157. Thong F.S., McLean C., Graham T.E. Plasma leptin in female athletes: relationship with body fat, reproductive, nutritional, and endocrine factors. J Appl Physiol 2000, 88(6):2037-2044.
158. Loucks A.B., Vaitukaitis J., Cameron J.L., Rogol A.D., Skrinar G., Warren M.P., et al. The reproductive system and exercise in women. Med Sci Sports Exerc 1992, 24(6 Suppl):S288-S293.
159. Loucks A.B., Verdun M., Heath E.M. Low energy availability, not stress of exercise, alters LH pulsatility in exercising women. J Appl Physiol 1998, 84(1):37-46.
160. Warren M.P., Goodman L.R. Exercise-induced endocrine pathologies. J Endocrinol Invest 2003, 26(9):873-878.
161. Williams N.I., Helmreich D.L., Parfitt D.B., Caston-Balderrama A., Cameron J.L. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab 2001, 86(11):5184-5193.
162. Bongain A., Isnard V., Gillet J.Y. Obesity in obstetrics and gynaecology. Eur J Obstet Gynecol Reprod Biol 1998, 77(2):217-228.
163. Fedorcsák P., Storeng R., Dale P.O., Tanbo T., Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000, 79(1):43-48.
164. Wang J.X., Davies M.J., Norman R.J. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001, 16(12):2606-2609.
165. Fedorcsak P., Dale P.O., Storeng R., Ertzeid G., Bjercke S., Oldereid N., et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004, 19(11):2523-2528.
166. Bellver J., Busso C., Pellicer A., Remohí J., Simón C. Obesity and assisted reproductive technology outcomes. Reprod Biomed Online 2006, 12(5):562-568.
167. Pasquali R., Pelusi C., Genghini S., Cacciari M., Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update 2003, 9(4):359-372.
168. Franks S., McCarthy M.I., Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. IntJ Androl 2006, 29(1):278-285. discussion 286-90.
169. Pasquali R., Gambineri A. Metabolic effects of obesity on reproduction. Reprod Biomed Online 2006, 12(5):542-551.
170. Willis D., Mason H., Gilling-Smith C., Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996, 81(1):302-309.
171. Franks S., Gilling-Smith C., Watson H., Willis D. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 1999, 28(2):361-378.
172. Erickson G.F., Magoffin D.A., Cragun J.R., Chang R.J. The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab 1990, 70(4):894-902.
173. De Leo V., La Marca A., Orvieto R., Morgante G. Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome. J Clin Endocrinol Metab 2000, 85(4):1598-1600.
174. Zhang Y., Scarpace P.J. The role of leptin in leptin resistance and obesity. Physiol Behav 2006, 88(3):249-256.
175. Gosman G.G., Katcher H.I., Legro R.S. Obesity and the role of gut and adipose hormones in female reproduction. Hum Reprod Update 2006, 12(5):585-601.
176. Pasquali R., Patton L., Pagotto U., Gambineri A. Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome. Minerva Ginecol 2005, 57(1):79-85.
177. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006, 91(11):4237M5.
178. Bhatia V. Insulin resistance in polycystic ovarian disease. South Med J 2005, 98(9):903-910. quiz 911-2,923.
179. Fleming R. The use of insulin sensitising agents in ovulation induction in women with polycystic ovary syndrome. Hormones (Athens) 2006, 5(3):171-178.
180. Siebert T.I., Kruger T.F., Steyn D.W., Nosarka S. Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. Fertil Steril 2006, 86(5):1432-1437.
181. Lloyd R.V., Jin L., Tsumanuma I., Vidal S., Kovacs K., Horvath E., et al. Leptin and leptin receptor in anterior pituitary function. Pituitary 2001, 4(1-2):33-47.
182. Gregoraszczuk E.L., Wojtowicz A.K., Ptak A., Nowak K. In vitro effect of leptin on steroids' secretion by FSH- and LH-treated porcine small, medium and large preovulatory follicles. Reprod Biol 2003, 3(3):227-239.
183. Gregoraszczuk E.L., Ptak A., Wojtowicz A.K., Gorska T., Nowak K.W. Estrus cycle-dependent action of leptin on basal and GH or IGF-I stimulated steroid secretion by whole porcine follicles. Endocr Regul 2004, 38(1):15-21.
184. Rodriguez-Pacheco F., Martinez-Fuentes A.J., Tovar S., Pinilla L., Tena-Sempere M., Dieguez C., et al. Regulation of pituitary cell function by adiponectin. Endocrinology 2007, 148(1):401-410.
185. Rivier C., Vale W. Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat. Endocrinology 1990, 127(2):849-856.
186. Mikuni M. Effect of interleukin-2 and interleukin-6 on ovary in the ovulatory period-establishment of the new ovarian perfusion system and influence of interleukins on ovulation rate and steroid secretion [in Japanese]. Hokkaido Igaku Zasshi 1995, 70(4):561-572.
187. Deura I., Harada T., Taniguchi F., Iwabe T., Izawa M., Terakawa N. Reduction of estrogen production by interleukin-6 in a human granulosa tumor cell line may have implications for endometriosis-associated infertility. Fertil Steril 2005, 83(Suppl 1):1086-1092.
188. Chun S.Y., Popliker M., Reich R., Tsafriri A. Localization of preovulatory expression of plasminogen activator inhibitor type-1 and tissue inhibitor of metalloproteinase type-1 mRNAs in the rat ovary. Biol Reprod 1992, 47(2):245-253.
189. Fernandez-Solari J., Prestifilippo J.P., Bornstein S.R., McCann S.M., Rettori V. Participation of the endocannabinoid system in the effect of TNF-alpha on hypothalamic release of gonadotropin-releasing hormone. Ann N Y Acad Sci 2006, 1088:238-250.
190. Wood J.R., Strauss J.F. Multiple signal transduction pathways regulate ovarian steroidogenesis. Rev Endocr Metab Disord 2002, 3(1):33-46.
191. Perera A.D., Verbalis J.G., Mikuma N., Majumdar S.S., Plant T.M. Cholecystokinin stimulates gonadotropin-releasing hormone release in the monkey (Macaca mulatta). Endocrinology 1993, 132(4):1723-1728.
192. Schreihofer D.A., Golden G.A., Cameron J.L. Cholecystokinin (CCK)-induced stimulation of luteinizing hormone (LH) secretion in adult male rhesus monkeys: examination of the role of CCK in nutritional regulation of LH secretion. Endocrinology 1993, 132(4):1553-1560.
193. Hashimoto R., Kimura F. Inhibition of gonadotropin secretion induced by cholecystokinin implants in the medial preoptic area by the dopamine receptor blocker, pimozide, in the rat. Neuroendocrinology 1986, 42(1):32-37.
194. Tena-Sempere M. Ghrelin: novel regulator of gonadal function. J Endocrinol Invest 2005, 28(5 Suppl):26-29.
195. Gambineri A., Pagotto U., De Lasio R., Meriggiola M.C., Costantino A., Patton L., et al. Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. J Endocrinol Invest 2005, 28(3):241-246.
196. Wade G.N., Jones J.E. Neuroendocrinology of nutritional infertility. Am J Physiol Regul Integr Comp Physiol 2004, 287(6):R1277-R1296.
197. Barreca A., Valli B., Cesarone A., Arvigo M., Balasini M. Battista La Sala G, et al. Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture. Fertil Steril 1998, 70(2):320-325.
198. Garraza M.H., Aguado L.I., De Bortoli M.A. In vitro effect of neuropeptides on ovary or celiac ganglion affects the release of progesterone from ovaries in the rat. Med Sci Monit 2004, 10(12):BR440-BR446.
199. Gonzalez M.I., Baker B.I., Wilson C.A. Stimulatory effect of melanin-concentrating hormone on luteinising hormone release. Neuroendocrinology 1997, 66(4):254-262.
200. Durando P.E., Celis M.E. In vitro effect of alpha-MSH administration on steroidogenesis of prepubertal ovaries. Peptides 1998, 19(4):667-675.
201. Caballero C., Celis M.E. The effect of the blockade of alpha-melanocyte-stimulating hormone on LH release in the rat. J Endocrinol 1993, 137(2):197-202.
202. Vulliemoz N.R., Xiao E., Xia-Zhang L., Wardlaw S.L., Ferin M. Central infusion of agouti-related peptide suppresses pulsatile luteinizing hormone release in the ovariectomized rhesus monkey. Endocrinology 2005, 146(2):784-789.
203. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002, 53(4):865-871.
204. Xiao E., Luckhaus J., Niemann W., Ferin M. Acute inhibition of gonadotropin secretion by corticotropin-releasing hormone in the primate: are the adrenal glands involved?. Endocrinology 1989, 124(4):1632-1637.
205. Xiao E.N., Ferin M. The inhibitory action of corticotropin-releasing hormone on gonadotropin secretion in the ovariectomized rhesus monkey is not mediated by adrenocorticotropic hormone. Biol Reprod 1988, 38(4):763-767.
206. Cates P.S., Li X.F., O'Byrne K.T. The influence of 17beta-oestradiol on corticotrophin-releasing hormone induced suppression of luteinising hormone pulses and the role of CRH in hypoglycaemic stress-induced suppression of pulsatile LH secretion in the female rat. Stress 2004, 7(2):113-118.
207. Turner A.I., Hemsworth P.H., Canny B.J., Tilbrook A.J. Sustained but not repeated acute elevation of cortisol impaired the luteinizing hormone surge, estrus, and ovulation in gilts. Biol Reprod 1999, 61(3):614-620.
208. Beak S.A., Heath M.M., Small C.J., Morgan D.G., Ghatei M.A., Taylor A.D., et al. Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. J Clin Invest 1998, 101(6):1334-41.
209. Wayne N.L., Kuwahara K. Beta-endorphin alters electrical activity of gonadotropin releasing hormone neurons located in the terminal nerve of the teleost medaka (Oryzias latipes). Gen Comp Endocrinol 2007, 150(1):41-47.
210. Gregoraszczuk E.L., Slomczynska M. Beta-endorphin inhibition of progesterone secretion by porcine granulosa cells during follicle development. Reprod Nutr Dev 1998, 38(3):227-234.
211. Faletti A., Viggiano J.M., Gimeno M.A. Beta-endorphin inhibits prostaglandin synthesis in rat ovaries and blocks induced ovulation. Prostaglandins 1995, 49(2):93-103.
212. Pau K.Y., Spies H.G. Neuroendocrine signals in the regulation of gonadotropin-releasing hormone secretion. Chin J Physiol 1997, 40(4):181-196.
213. Martin A.I., Fernandez-Ruiz J., Lopez-Calderon A. Effects of catecholamine synthesis inhibitors and adrenergic receptor antagonists on restraint-induced LH release. J Endocrinol 1995, 144(3):511-515.
214. Maeda K., Cagampang F.R., Coen C.W., Tsukamura H. Involvement of the catecholaminergic input to the paraventricular nucleus and of corticotropin-releasing hormone in the fasting-induced suppression of luteinizing hormone release in female rats. Endocrinology 1994, 134(4):1718-1722.
215. Miszkiel G., Kotwica J. Mechanism of action of noradrenaline on secretion of progesterone and oxytocin by the bovine corpus luteum in vitro. Acta Vet Hung 2001, 49(1):39-51.
216. Fernandez-Fernandez R., Tena-Sempere M., Navarro V.M., Barreiro M.L., Castellano J.M., Aguilar E., et al. Effects of ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: in vivo and in vitro studies. Neuroendocrinology 2005, 82(5-6):245-255.
217. Pinilla L., Fernandez-Fernandez R., Vigo E., Navarro V.M., Roa J., Castellano J.M., et al. Stimulatory effect of PYY-(3-36) on gonadotropin secretion is potentiated in fasted rats. Am J Physiol Endocrinol Metab 2006, 290(6):E1162-E1171.
218. Tena-Sempere M. KiSS-1 and reproduction: focus on its role in the metabolic regulation of fertility. Neuroendocrinology 2006, 83(5-6):275-281.
219. Castellano J.M., Gaytan M., Roa J., Vigo E., Navarro V.M., Bellido C., et al. Expression of KiSS-1 in rat ovary: putative local regulator of ovulation?. Endocrinology 2006, 147(10):4852-4862.